Are Industry-Funded Clinical Trials Inherently Biased?

Missed the big news last week on the article published last week in Cancer, written by University of North Carolina (Chapel Hill) oncologist, Dr. Jeffrey Peppercorn. The research showed that results from industry-funded clinical trials tend to be more favorable than those from non-industry-funded trials. For more on his research and an interview with Dr. Peppercorn, click here.